Stock Analysis on Net
Stock Analysis on Net

Cigna Group (NYSE:CI)

This company has been moved to the archive! The financial data has not been updated since February 27, 2025.

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Cigna Group, common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Current insurance and contractholder liabilities 3.46 3.47 3.61 3.78 3.61 4.91 5.02 4.84 3.74 4.23 3.70 3.72 3.43 3.84 3.79 3.78 3.41 3.26 3.17 3.25
Pharmacy and other service costs payable 18.26 18.27 17.69 15.86 12.97 12.91 12.41 11.90 11.86 11.56 10.77 9.98 9.88 9.53 9.38 9.05 8.59 7.83 7.43 6.98
Accounts payable 5.96 5.40 5.97 5.30 5.60 5.13 5.38 4.97 5.40 4.76 4.68 4.35 4.30 3.67 3.66 3.71 3.52 3.33 3.39 3.61
Accrued expenses and other liabilities 6.02 5.66 5.79 5.78 6.52 6.46 5.66 6.20 5.56 5.54 5.07 5.13 4.73 4.77 4.68 5.21 5.48 4.47 5.01 4.90
Short-term debt 1.95 1.63 1.10 1.12 1.82 2.04 3.08 2.31 2.08 2.42 1.57 1.42 1.64 1.75 0.99 0.27 2.17 4.03 2.98 2.81
Liabilities of businesses held for sale 1.55 1.76 1.45 2.10 1.38 0.00 0.00 0.00 0.00 0.00 3.83 4.01 4.15 0.00 0.00 0.00 0.00 4.50 4.45 4.55
Current liabilities 37.19% 36.20% 35.62% 33.95% 31.89% 31.45% 31.55% 30.23% 28.64% 28.51% 29.63% 28.61% 28.13% 23.56% 22.51% 22.01% 23.17% 27.42% 26.42% 26.10%
Non-current insurance and contractholder liabilities 6.58 6.71 6.72 6.95 7.14 7.54 7.71 7.97 7.98 8.08 7.72 7.97 8.11 10.75 10.81 10.80 10.84 10.13 10.06 10.24
Deferred tax liabilities, net 4.47 4.31 4.47 4.59 4.70 5.00 5.06 5.21 5.39 5.39 5.25 5.31 5.39 5.73 5.75 5.81 5.75 5.71 5.74 5.86
Other non-current liabilities 2.06 1.92 2.28 2.39 2.25 1.96 1.72 1.82 2.18 2.20 2.08 2.19 2.43 2.76 2.81 2.95 2.98 2.84 2.99 2.92
Long-term debt 18.56 19.18 19.41 20.28 18.43 18.77 18.74 19.68 19.52 19.48 20.30 20.32 20.10 20.49 20.50 20.76 19.01 18.46 19.91 20.78
Separate account liabilities 4.67 4.85 4.78 4.84 4.86 4.70 4.88 4.96 5.06 5.03 4.91 5.34 5.38 5.93 6.01 5.98 5.84 5.38 5.18 4.94
Liabilities of businesses held for sale, non-current 0.00 0.00 0.00 0.00 0.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Non-current liabilities 36.35% 36.97% 37.66% 39.05% 37.77% 37.97% 38.11% 39.64% 40.12% 40.19% 40.26% 41.14% 41.41% 45.66% 45.87% 46.29% 44.41% 42.53% 43.88% 44.74%
Total liabilities 73.54% 73.17% 73.29% 72.99% 69.66% 69.42% 69.66% 69.86% 68.77% 68.70% 69.88% 69.75% 69.54% 69.22% 68.38% 68.30% 67.59% 69.95% 70.30% 70.84%
Redeemable noncontrolling interests 0.00 0.00 0.00 0.00 0.07 0.04 0.04 0.05 0.05 0.03 0.03 0.04 0.03 0.04 0.03 0.04 0.04 0.04 0.02 0.02
Common stock, $0.01 par value per share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Additional paid-in capital 20.07 19.78 19.97 19.78 20.08 20.42 20.28 20.50 21.01 20.38 19.61 19.48 19.09 18.85 19.07 19.24 18.64 17.98 17.98 18.46
Accumulated other comprehensive loss -1.50 -1.37 -1.57 -1.52 -1.22 -1.42 -1.25 -1.20 -0.97 -1.39 -1.36 -0.98 -0.57 -0.75 -0.70 -0.81 -0.55 -0.34 -0.49 -0.99
Retained earnings 27.92 26.95 27.10 26.76 27.27 27.39 26.61 26.25 26.31 25.69 22.69 21.90 21.04 20.62 19.79 19.32 18.38 15.27 14.44 13.77
Treasury stock, at cost -20.17 -18.66 -18.92 -18.14 -15.87 -15.86 -15.36 -15.48 -15.18 -13.45 -10.87 -10.21 -9.15 -7.98 -6.57 -6.09 -4.10 -2.90 -2.26 -2.10
Shareholders’ equity 26.32% 26.70% 26.59% 26.89% 30.26% 30.53% 30.29% 30.07% 31.18% 31.23% 30.07% 30.20% 30.42% 30.74% 31.59% 31.66% 32.37% 30.01% 29.67% 29.14%
Other noncontrolling interests 0.13 0.13 0.13 0.11 0.01 0.01 0.01 0.01 0.01 0.03 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total equity 26.46% 26.83% 26.71% 27.01% 30.27% 30.54% 30.30% 30.08% 31.18% 31.26% 30.09% 30.21% 30.43% 30.75% 31.59% 31.66% 32.38% 30.02% 29.68% 29.14%
Total liabilities and equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).

Current insurance and contractholder liabilities
This item displayed moderate fluctuations, initially increasing from 3.25% in March 2020 to a peak of 5.02% in June 2023, followed by a decline to approximately 3.46% by December 2024. The trend suggests volatility with some upward pressure followed by correction towards prior levels.
Pharmacy and other service costs payable
A consistent upward trend is evident, starting at 6.98% in March 2020 and increasing steadily to 18.26% by December 2024. This sustained rise may indicate growing operational costs associated with pharmacy and related services.
Accounts payable
Accounts payable as a percentage of total liabilities and equity rose gradually from 3.61% to nearly 5.96% over the observed period, highlighting a gradual build-up in short-term obligations to suppliers or service providers.
Accrued expenses and other liabilities
After a slight dip early in the period, accrued expenses and other liabilities climbed from 4.9% in March 2020 to a higher range around 6% by late 2023 and remained in the 5.6% to 6.0% vicinity by the end of 2024, suggesting a stable but slightly increased expense accrual practice.
Short-term debt
The short-term debt ratio showed a considerable decline from early 2020 to mid-2021, falling as low as 0.27% in March 2021, followed by moderate fluctuations in the 1% to 3% range thereafter, indicating variability but overall lower reliance on short-term borrowing.
Liabilities of businesses held for sale
This category exhibited incomplete data and appeared in certain quarters with values decreasing from about 4.55% in early 2020 to roughly 1.55% by March 2024, signaling either divestiture or reduction of related liabilities.
Current liabilities
Current liabilities showed a general upward trend, increasing from approximately 26.1% in March 2020 to 37.19% by December 2024. This growth reflects an expanding portion of obligations due within one year in relation to total liabilities and equity.
Non-current insurance and contractholder liabilities
A downward trend is apparent, declining from around 10.24% in March 2020 to 6.58% by December 2024, indicating reduced long-term obligations related to insurance and contractholders.
Deferred tax liabilities, net
Deferred tax liabilities remained relatively stable, with a minor gradual decrease from about 5.86% in March 2020 to approximately 4.47% by late 2024, reflecting consistent but slightly diminishing deferred tax obligations.
Other non-current liabilities
Other non-current liabilities gradually decreased over the period, falling from nearly 2.92% in early 2020 to around 2.06% by December 2024, indicating a mild reduction in other long-term liabilities.
Long-term debt
Long-term debt as a percentage of total liabilities and equity showed minor fluctuations but generally remained stable between roughly 18.5% and 21%, with a slight decline toward the end of the period, suggesting relatively steady management of long-term debt levels.
Separate account liabilities
These liabilities stayed relatively consistent, fluctuating narrowly around 5% throughout the period, indicating stable liabilities associated with separate accounts.
Non-current liabilities
Overall non-current liabilities decreased steadily from 44.74% in March 2020 to about 36.35% by December 2024, reflecting a notable shift toward lower long-term obligations relative to total liabilities and equity.
Total liabilities
Total liabilities remained relatively stable between approximately 68% and 73%, with a slight upward trend in the final two years reaching 73.54%, indicating a moderately increasing proportion of liabilities versus equity on the balance sheet.
Shareholders’ equity
Shareholders' equity held fairly steady near 30% for most of the period until early 2023, after which it declined to about 26% by December 2024. The reduction in equity proportion may signal buybacks, distributions, or other equity changes.
Additional paid-in capital
This component showed gradual growth from 18.46% to above 20% by 2024, indicating incremental increases in capital contributed by shareholders beyond par value.
Accumulated other comprehensive loss
The accumulated comprehensive loss fluctuated with a general tendency towards increased losses, moving from around -0.99% to approximately -1.5%, suggesting growing unrealized losses impacting equity.
Retained earnings
Retained earnings steadily rose from 13.77% in March 2020 to nearly 28% by December 2024, reflecting ongoing profitability and earnings retention within the company.
Treasury stock, at cost
Treasury stock showed marked growth in negative proportion, increasing from -2.1% in early 2020 to -20.17% at the end of 2024, indicating extensive stock repurchase activity reducing shareholders' equity.
Total equity
Total equity mirrored shareholders’ equity trends, overall decreasing from approximately 29% to just above 26% over the period, consistent with the impact of treasury stock increases and retained earnings growth.